Arcam, listed on NASDAQ OMX, has received an order for two Arcam Q10 systems
from the strategic partner DiSanto Technology Inc. in the US. The systems will
be used for manufacturing of orthopedic implants.
In spring 2013 Arcam and Disanto Technology Inc. entered into a strategic
cooperation in order to make a joint development of customers for contract
manufacturing of advanced orthopedics implants based on Arcam´s EBM technology.
In connection with the cooperation DiSanto bought two EBM systems. With this new
order DiSanto increases its EBM based production.
“The cooperation with DiSanto is developing very well and with this new order
DiSanto increases its manufacturing capacity to meet the demand on EBM
manufactured implants”, says Magnus René, CEO of Arcam.
For further information please contact:
Magnus René, CEO Arcam AB
Tel: 0046 31 710 32 00, alt. cell: 0046 702 79 89 99, or e-mail:
Arcam provides a cost-efficient Additive Manufacturing solution for production
of metal components. The technology offers freedom in design combined with
excellent material properties and high productivity. Arcam’s market is global
with customers mainly in the orthopedic and aerospace industries. The company
was founded in 1997 and is listed on NASDAQ OMX Stockholm, Sweden. Head office
and production facilities are located in Mölndal, Sweden. Support offices are
located in the US, UK, Italy and China.
Arcam AB • Krokslätts Fabriker 27A • SE-431 37 Mölndal, Sweden • 46-31-710 32 00
GlobeNewswire, a NASDAQ OMX company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.